Related Experiment Video

Updated: Jun 3, 2026

Analysis of Translation Initiation During Stress Conditions by Polysome Profiling
10:59

Analysis of Translation Initiation During Stress Conditions by Polysome Profiling

Published on: May 19, 2014

Inhibitors of translation initiation as cancer therapeutics

Lisa Lindqvist1, Jerry Pelletier

  • 1Department of Biochemistry, McIntyre Medical Sciences Building, Room 810, 3655 Promenade Sir William Osler, McGill University, Montreal, QC, H3G 1Y6, Canada.

Future Medicinal Chemistry
|March 24, 2011
PubMed

Insights

Targeting protein synthesis through translation initiation inhibitors shows promise for cancer therapy. These small molecules are validating protein synthesis as a key target for curtailing tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Deregulated translation initiation is a key factor in cancer development and progression.
  • Several translation initiation factors are linked to oncogenes, elevated in tumors, and associated with drug resistance.
  • Clinical trials targeting upstream pathways like mTOR have yielded mixed results, increasing interest in alternative strategies.

Purpose of the Study:

  • To explore the potential of targeting translation initiation as a novel chemotherapeutic strategy.
  • To identify the most effective targets within the translation initiation pathway for cancer treatment.
  • To investigate the optimal clinical application of translation inhibitors, as single agents or adjuvant therapy.

Main Methods:

  • Characterization of inhibitors targeting the ribosome recruitment phase, including eukaryotic initiation factor (eIF) 4E and eIF4A inhibitors.
  • Evaluation of inhibitor activity in preclinical cancer models.
  • Systematic exploration of the clinical framework for employing translation inhibitors.

Main Results:

  • Several inhibitors targeting eIF4E and eIF4A have been developed and characterized.
  • Some of these inhibitors demonstrate significant activity in preclinical cancer models.
  • Small-molecule inhibitors of translation initiation are validating protein synthesis as a viable therapeutic target.

Conclusions:

  • Targeting translation initiation represents a promising approach for developing new cancer chemotherapeutics.
  • Identifying the most susceptible targets within this pathway is crucial for maximizing therapeutic efficacy.
  • Further research is needed to determine the optimal clinical use of translation inhibitors in cancer treatment.

More Related Videos

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling10:00

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling

Published on: October 28, 2014

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...